References
- Sorlozano A, Gutierrez J, Salmeron A et al. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extendedspectrum beta-lactamase-producing Escherichia coli in Granada, Spain. Int J Antimicrob Agents 2006; 28: 532–6.
- Sorlozano A, Gutierrez J, Roman E et al. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae. Diagn Microbiol Infect Dis 2007; 58: 487–9.
- Pitout JDD, Le P, Church DL, Gregson DB, Laupland KB. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam. Int J Antimicrob Agents 2008; 32: 333–8.
- DiPersio JR, Dowzicky MJ. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents 2007; 29: 518–27.
- Lu C-T, Chuang Y-C, Sun W et al. Nationwide surveillance in Taiwan of the in vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 2008; 32 (Suppl 3): S179–83.
- Bouchillon SK, Iredell JR, Barkham T, Lee K, Dowzicky MJ. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Int J Antimicrob Agents 2009; 33: 130–6.
- Rodloff AC, Leclercq R, Debbia EA, Cantón R, Oppenheim BA, Dowzicky MJ. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial. Clin Microbiol Infect 2008; 14: 307–14.
- Gales AC, Sader HS, Fritsche TR. Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers. Diagn Microbiol Infect Dis 2008; 60: 421–7.
- Timurkaynak F, Arslan H, Azap OK et al. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients. Burns 2008; 34: 1033–6.
- Pillar CM, Draghi DC, Dowzicky MJ, Sahm DF. In vitro activity of tigecycline against Gram-positive and Gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008; 46: 2862–7.